Alexander Azoy

Alexander Azoy, listed as finance chief, appears in our data through filings on Arcus Biosciences, Inc. shares, published by SEC (Form 4). In total, 18 filings cover trades dated from 3 July 2023 to 21 August 2026.

The open-market record consists of 9 sales worth €265k, with no purchase. The rest of the record consists of 4 share grants and 2 option exercises. In 2026 alone, the filings show no purchases and 2 sales.

The newest entry dates from 24 August 2026: an open-market sale of €73k, in Arcus Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.